Drugs / H3N2v MN 2010/AA ca live attenuated influenza vaccine (LAIV)
H3N2v MN 2010/AA ca live attenuated influenza vaccine (LAIV)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02883426 | Sep 2016 → Jan 2017 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H3N2v MN 2010/AA ca live attenuated influenza vaccine (LAIV) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02883426 ↗ |
| Modality | Vaccine | “live attenuated influenza vaccine” NCT02883426 ↗ |
| Route | Intranasal | “administered intranasally” NCT02883426 ↗ |